MID-VOLUME · HOSP-HEAVY
cefepime Side Effects
cefepime (also sold as Maxipime) sits MID-VOLUME #280 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 59.4% mention hospitalization (8,120 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 13,667
- FAERS reports
FDA Adverse Event Reporting System extract for cefepime. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
cefepime: 59.4% mention hospitalization (8,120 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #280 of 524 by FAERS report count.
Mid-book FAERS page for cefepime (Maxipime) (13,667 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2004–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ACUTE KIDNEY INJURY leads 1,130 of 13,667 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (3,924 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (2,974 reports, 21.8%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 300 |
| RESPIRATORY FAILURE | 275 |
| SEPTIC SHOCK | 273 |
| SEPSIS | 266 |
| PNEUMONIA | 262 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 240 |
| ACUTE KIDNEY INJURY | 199 |
| PYREXIA | 189 |
| HYPOTENSION | 188 |
| FEBRILE NEUTROPENIA | 167 |
| CARDIAC ARREST | 166 |
| RENAL FAILURE | 147 |
| CONDITION AGGRAVATED | 133 |
| THROMBOCYTOPENIA | 130 |
| HYPOXIA | 114 |
| ENCEPHALOPATHY | 111 |
| DYSPNOEA | 106 |
| NEUTROPENIA | 104 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (8,120, 59.4% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| ACUTE KIDNEY INJURY | 707 |
| PYREXIA | 653 |
| FEBRILE NEUTROPENIA | 541 |
| PNEUMONIA | 526 |
| HYPOTENSION | 394 |
| SEPSIS | 373 |
| ENCEPHALOPATHY | 344 |
| NEUTROPENIA | 328 |
| THROMBOCYTOPENIA | 326 |
| SEPTIC SHOCK | 311 |
| RESPIRATORY FAILURE | 306 |
| DIARRHOEA | 300 |
| CONDITION AGGRAVATED | 288 |
| CONFUSIONAL STATE | 274 |
| DYSPNOEA | 268 |
| ANAEMIA | 256 |
| NAUSEA | 252 |
| DRUG INTERACTION | 229 |
How to read cefepime FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 13,667 voluntary reports linked to cefepime (Maxipime), 2004-2025. Death is listed on 2,974 (21.8%). Hospitalization appears on 8,120 (59.4%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 59.4% mention hospitalization (8,120 reports).
Read with cefepime
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 13,500 FAERS cases (Δ 167 lighter vs cefepime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,451 FAERS cases (Δ 216 lighter vs cefepime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,400 FAERS cases (Δ 267 lighter vs cefepime); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 13,367 FAERS cases (Δ 300 lighter vs cefepime); DEATH-HEAVY · HOSP-HEAVY · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 40.3 pp vs cefepime's DEATH-HEAVY): CASELOAD · HOSP-MID.
cefepime stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.